Quick Answer
HCW Biologics Inc. reported Total Assets of $24.52 million for fiscal year 2025.
HCW Biologics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $24.52M | -18.9% |
| 2024 | $30.24M | +6.0% |
| 2023 | $28.51M | -39.1% |
| 2022 | $46.81M | -12.5% |
| 2021 | $53.51M | +247.5% |
| 2020 | $15.40M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.45M | -4.2% | -12.0% |
| June 30, 2025 | $28.91M | +7.8% | +10.0% |
| March 31, 2025 | $26.29M | -13.6% | -13.1% |
| December 31, 2024 | $30.24M | +6.0% | +13.9% |
| September 30, 2024 | $26.56M | -25.4% | -1.0% |
| June 30, 2024 | $26.82M | -32.1% | -11.9% |
| March 31, 2024 | $30.43M | -30.1% | +6.7% |
| December 31, 2023 | $28.51M | -39.1% | -19.9% |
- HCW Biologics Inc. showed a decrease of -18.9% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, HCW Biologics Inc.’s total assets has grown by 59.2% (from $15.40 million to $24.52 million).
- The most recent figure is from HCW Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: